Showing 12 posts of 12 posts found.

Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

Eliquis image

Anti-blood clotting drug Eliquis gets NICE nod

March 6, 2015
Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting

Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …

eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

Pradaxa image

Pradaxa gets DVT indication

June 6, 2014
Sales and Marketing Boehringer, DVT, Pradaxa, blood, dabigatran etexilate, thinner

Pradaxa has been given approval in Europe to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) just a week …

Daiichi Sankyo image

Edoxaban ‘as effective as warfarin’

September 2, 2013
Sales and Marketing DVT, Daiichi Sankyo, VTE, warfarin

Daiichi Sankyo is celebrating after its once-a-day blood thinner edoxaban proved as effective as warfarin in a late-stage trial, although …

Eliquis image

Eliquis poised for new US approval

July 12, 2013
Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin

Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …

eliquis image

VTE boost for Eliquis

July 2, 2013
Research and Development, Sales and Marketing AMPLIFY, BMS, DVT, Eliquis, Pfizer

Bristol-Myers Squibb and Pfizer’s oral blood thinner Eliquis is as efficient as standard of care and causes less bleeding in …

Xarelto image

Xarelto gets new EU approval

November 21, 2012
Sales and Marketing AF, Bayer, DVT, Xarelto

Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …

Xarelto image

NICE yes for Xarelto to treat blood clots

July 25, 2012
Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto

NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …

Xarelto picture

NICE recommends Xarelto for stroke prevention

May 23, 2012
Sales and Marketing Bayer, DVT, NICE, Pradaxa, Xarelto, anticoagulant

NICE is recommending Bayer’s anticoagulant pill Xarelto to help reduce the risk of stroke in certain patients.  The watchdog’s final …

Xarelto picture

NICE wants more information on Xarelto

March 13, 2012
Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …

Bayer submits new Xarelto indications for European approval

January 6, 2011
Sales and Marketing Bayer, DVT, Xarelto, atrial fibrillation, deep vein thrombosis, pulmonary embolism, rivaroxaban, stroke prevention

Bayer is seeking European regulatory approval for a batch of new indications for its oral anticoagulant Xarelto. The company is …

Latest content